ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HMO Infant Formula Market Research Report 2026
Published Date: 2026-04-28
|
Report Code: QYRE-Auto-34H17237
Home | Market Reports | Health| Nutrition
Global HMO Infant Formula Market Research Report 2024
BUY CHAPTERS

Global HMO Infant Formula Market Research Report 2026

Code: QYRE-Auto-34H17237
Report
2026-04-28
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Mead Johnson（Reckitt）
Biostime
Nestlé（Wyeth Nutrition）
Danone (Aptamil)
FrieslandCampina (Friso)
Yili Group (Ausnutria Dairy)

HMO Infant Formula Market Size

The global HMO Infant Formula market was valued at US$ 4236 million in 2025 and is anticipated to reach US$ 8615 million by 2032, at a CAGR of 10.8% from 2026 to 2032.

HMO Infant Formula Market

HMO Infant Formula Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on HMO Infant Formula competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Global key players of HMO Infant Formula include Nestlé (Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Abbott, Mead Johnson(Reckitt), etc. The top five players hold a share about 94%. Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately. In terms of product type, 2'-FL is the largest segment, accounting for a share about 96%. In terms of application, Online Channel is the largest field with a share about 33 percent.
This report delivers a comprehensive overview of the global HMO Infant Formula market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding HMO Infant Formula. The HMO Infant Formula market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global HMO Infant Formula market comprehensively. Regional market sizes by Type, by Sales Channel, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist HMO Infant Formula manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Sales Channel, and by region.
Market Segmentation

Scope of HMO Infant Formula Market Report

Report Metric Details
Report Name HMO Infant Formula Market
Accounted market size in 2025 US$ 4236 million
Forecasted market size in 2032 US$ 8615 million
CAGR 10.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 2'-Fucosyllactose (2'-FL)
  • Others
  • by Sales Channel
  • Online Channel
  • Specialty Store
  • Supermarket
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Sales Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for HMO Infant Formula manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines HMO Infant Formula sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Sales Channel, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is HMO Infant Formula Market growing?

Ans: The HMO Infant Formula Market witnessing a CAGR of 10.8% during the forecast period 2026-2032.

What is the HMO Infant Formula Market size in 2032?

Ans: The HMO Infant Formula Market size in 2032 will be US$ 8615 million.

What is the market share of major companies in HMO Infant Formula Market?

Ans: The top five players hold a share about 94%.

What is the HMO Infant Formula Market share by region?

Ans: Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately.

Who are the main players in the HMO Infant Formula Market report?

Ans: The main players in the HMO Infant Formula Market are Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy)

What are the Type segmentation covered in the HMO Infant Formula Market report?

Ans: The Types covered in the HMO Infant Formula Market report are 2'-Fucosyllactose (2'-FL), Others, by Sales Channel, Online Channel, Specialty Store, Supermarket

1 HMO Infant Formula Market Overview
1.1 Product Definition
1.2 HMO Infant Formula by Type
1.2.1 Global HMO Infant Formula Market Value by Type: 2025 vs 2032
1.2.2 2'-Fucosyllactose (2'-FL)
1.2.3 Others
1.3 HMO Infant Formula by Sales Channel
1.3.1 Global HMO Infant Formula Market Value by Sales Channel: 2025 vs 2032
1.3.2 Online Channel
1.3.3 Specialty Store
1.3.4 Supermarket
1.3.5 Others
1.4 Global HMO Infant Formula Market Size Estimates and Forecasts
1.4.1 Global HMO Infant Formula Revenue 2021–2032
1.4.2 Global HMO Infant Formula Sales 2021–2032
1.4.3 Global HMO Infant Formula Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 HMO Infant Formula Market Competition by Manufacturers
2.1 Global HMO Infant Formula Sales Market Share by Manufacturers (2021–2026)
2.2 Global HMO Infant Formula Revenue Market Share by Manufacturers (2021–2026)
2.3 Global HMO Infant Formula Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of HMO Infant Formula, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of HMO Infant Formula, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of HMO Infant Formula, Product Types and Applications
2.7 Global Key Manufacturers of HMO Infant Formula, Date of Entry into the Industry
2.8 Global HMO Infant Formula Market Competitive Situation and Trends
2.8.1 Global HMO Infant Formula Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global HMO Infant Formula Players Market Share by Revenue
2.8.3 Global HMO Infant Formula Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HMO Infant Formula Market Scenario by Region
3.1 Global HMO Infant Formula Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global HMO Infant Formula Sales by Region: 2021–2032
3.2.1 Global HMO Infant Formula Sales by Region: 2021–2026
3.2.2 Global HMO Infant Formula Sales by Region: 2027–2032
3.3 Global HMO Infant Formula Revenue by Region: 2021–2032
3.3.1 Global HMO Infant Formula Revenue by Region: 2021–2026
3.3.2 Global HMO Infant Formula Revenue by Region: 2027–2032
3.4 North America HMO Infant Formula Market Facts & Figures by Country
3.4.1 North America HMO Infant Formula Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America HMO Infant Formula Sales by Country (2021–2032)
3.4.3 North America HMO Infant Formula Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe HMO Infant Formula Market Facts & Figures by Country
3.5.1 Europe HMO Infant Formula Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe HMO Infant Formula Sales by Country (2021–2032)
3.5.3 Europe HMO Infant Formula Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HMO Infant Formula Market Facts & Figures by Region
3.6.1 Asia Pacific HMO Infant Formula Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific HMO Infant Formula Sales by Region (2021–2032)
3.6.3 Asia Pacific HMO Infant Formula Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HMO Infant Formula Market Facts & Figures by Country
3.7.1 Latin America HMO Infant Formula Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America HMO Infant Formula Sales by Country (2021–2032)
3.7.3 Latin America HMO Infant Formula Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HMO Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa HMO Infant Formula Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa HMO Infant Formula Sales by Country (2021–2032)
3.8.3 Middle East and Africa HMO Infant Formula Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HMO Infant Formula Sales by Type (2021–2032)
4.1.1 Global HMO Infant Formula Sales by Type (2021–2026)
4.1.2 Global HMO Infant Formula Sales by Type (2027–2032)
4.1.3 Global HMO Infant Formula Sales Market Share by Type (2021–2032)
4.2 Global HMO Infant Formula Revenue by Type (2021–2032)
4.2.1 Global HMO Infant Formula Revenue by Type (2021–2026)
4.2.2 Global HMO Infant Formula Revenue by Type (2027–2032)
4.2.3 Global HMO Infant Formula Revenue Market Share by Type (2021–2032)
4.3 Global HMO Infant Formula Price by Type (2021–2032)
5 Segment by Sales Channel
5.1 Global HMO Infant Formula Sales by Sales Channel (2021–2032)
5.1.1 Global HMO Infant Formula Sales by Sales Channel (2021–2026)
5.1.2 Global HMO Infant Formula Sales by Sales Channel (2027–2032)
5.1.3 Global HMO Infant Formula Sales Market Share by Sales Channel (2021–2032)
5.2 Global HMO Infant Formula Revenue by Sales Channel (2021–2032)
5.2.1 Global HMO Infant Formula Revenue by Sales Channel (2021–2026)
5.2.2 Global HMO Infant Formula Revenue by Sales Channel (2027–2032)
5.2.3 Global HMO Infant Formula Revenue Market Share by Sales Channel (2021–2032)
5.3 Global HMO Infant Formula Price by Sales Channel (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott HMO Infant Formula Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott HMO Infant Formula Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Mead Johnson（Reckitt）
6.2.1 Mead Johnson（Reckitt） Company Information
6.2.2 Mead Johnson（Reckitt） Description and Business Overview
6.2.3 Mead Johnson（Reckitt） HMO Infant Formula Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mead Johnson（Reckitt） HMO Infant Formula Product Portfolio
6.2.5 Mead Johnson（Reckitt） Recent Developments/Updates
6.3 Nestlé（Wyeth Nutrition）
6.3.1 Nestlé（Wyeth Nutrition） Company Information
6.3.2 Nestlé（Wyeth Nutrition） Description and Business Overview
6.3.3 Nestlé（Wyeth Nutrition） HMO Infant Formula Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Nestlé（Wyeth Nutrition） HMO Infant Formula Product Portfolio
6.3.5 Nestlé（Wyeth Nutrition） Recent Developments/Updates
6.4 Danone (Aptamil)
6.4.1 Danone (Aptamil) Company Information
6.4.2 Danone (Aptamil) Description and Business Overview
6.4.3 Danone (Aptamil) HMO Infant Formula Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Danone (Aptamil) HMO Infant Formula Product Portfolio
6.4.5 Danone (Aptamil) Recent Developments/Updates
6.5 FrieslandCampina (Friso)
6.5.1 FrieslandCampina (Friso) Company Information
6.5.2 FrieslandCampina (Friso) Description and Business Overview
6.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 FrieslandCampina (Friso) HMO Infant Formula Product Portfolio
6.5.5 FrieslandCampina (Friso) Recent Developments/Updates
6.6 Biostime
6.6.1 Biostime Company Information
6.6.2 Biostime Description and Business Overview
6.6.3 Biostime HMO Infant Formula Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Biostime HMO Infant Formula Product Portfolio
6.6.5 Biostime Recent Developments/Updates
6.7 Yili Group (Ausnutria Dairy)
6.7.1 Yili Group (Ausnutria Dairy) Company Information
6.7.2 Yili Group (Ausnutria Dairy) Description and Business Overview
6.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio
6.7.5 Yili Group (Ausnutria Dairy) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HMO Infant Formula Industry Chain Analysis
7.2 HMO Infant Formula Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HMO Infant Formula Production Mode & Process Analysis
7.4 HMO Infant Formula Sales and Marketing
7.4.1 HMO Infant Formula Sales Channels
7.4.2 HMO Infant Formula Distributors
7.5 HMO Infant Formula Customer Analysis
8 HMO Infant Formula Market Dynamics
8.1 HMO Infant Formula Industry Trends
8.2 HMO Infant Formula Market Drivers
8.3 HMO Infant Formula Market Challenges
8.4 HMO Infant Formula Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott
Mead Johnson（Reckitt）
Biostime
Nestlé（Wyeth Nutrition）
Danone (Aptamil)
FrieslandCampina (Friso)
Yili Group (Ausnutria Dairy)
List of Tables
 Table 1. Global HMO Infant Formula Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global HMO Infant Formula Market Value by Sales Channel (US$ Million), 2025 vs 2032
 Table 3. Global HMO Infant Formula Market Competitive Situation by Manufacturers in 2025
 Table 4. Global HMO Infant Formula Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global HMO Infant Formula Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global HMO Infant Formula Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global HMO Infant Formula Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market HMO Infant Formula Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of HMO Infant Formula, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of HMO Infant Formula, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of HMO Infant Formula, Product Types and Applications
 Table 12. Global Key Manufacturers of HMO Infant Formula, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HMO Infant Formula Companies by Tier (Tier 1, Tier 2, Tier 3), based on HMO Infant Formula Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HMO Infant Formula Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global HMO Infant Formula Sales by Region (Tons), 2021–2026
 Table 18. Global HMO Infant Formula Sales Market Share by Region (2021–2026)
 Table 19. Global HMO Infant Formula Sales by Region (Tons), 2027–2032
 Table 20. Global HMO Infant Formula Sales Market Share by Region (2027–2032)
 Table 21. Global HMO Infant Formula Revenue by Region (US$ Million), 2021–2026
 Table 22. Global HMO Infant Formula Revenue Market Share by Region (2021–2026)
 Table 23. Global HMO Infant Formula Revenue by Region (US$ Million), 2027–2032
 Table 24. Global HMO Infant Formula Revenue Market Share by Region (2027–2032)
 Table 25. North America HMO Infant Formula Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America HMO Infant Formula Sales by Country (Tons), 2021–2026
 Table 27. North America HMO Infant Formula Sales by Country (Tons), 2027–2032
 Table 28. North America HMO Infant Formula Revenue by Country (US$ Million), 2021–2026
 Table 29. North America HMO Infant Formula Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe HMO Infant Formula Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe HMO Infant Formula Sales by Country (Tons), 2021–2026
 Table 32. Europe HMO Infant Formula Sales by Country (Tons), 2027–2032
 Table 33. Europe HMO Infant Formula Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe HMO Infant Formula Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific HMO Infant Formula Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific HMO Infant Formula Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific HMO Infant Formula Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific HMO Infant Formula Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific HMO Infant Formula Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America HMO Infant Formula Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America HMO Infant Formula Sales by Country (Tons), 2021–2026
 Table 42. Latin America HMO Infant Formula Sales by Country (Tons), 2027–2032
 Table 43. Latin America HMO Infant Formula Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America HMO Infant Formula Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa HMO Infant Formula Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa HMO Infant Formula Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa HMO Infant Formula Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa HMO Infant Formula Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa HMO Infant Formula Revenue by Country (US$ Million), 2027–2032
 Table 50. Global HMO Infant Formula Sales (Tons) by Type (2021–2026)
 Table 51. Global HMO Infant Formula Sales (Tons) by Type (2027–2032)
 Table 52. Global HMO Infant Formula Sales Market Share by Type (2021–2026)
 Table 53. Global HMO Infant Formula Sales Market Share by Type (2027–2032)
 Table 54. Global HMO Infant Formula Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global HMO Infant Formula Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global HMO Infant Formula Revenue Market Share by Type (2021–2026)
 Table 57. Global HMO Infant Formula Revenue Market Share by Type (2027–2032)
 Table 58. Global HMO Infant Formula Price (US$/kg) by Type (2021–2026)
 Table 59. Global HMO Infant Formula Price (US$/kg) by Type (2027–2032)
 Table 60. Global HMO Infant Formula Sales (Tons) by Sales Channel (2021–2026)
 Table 61. Global HMO Infant Formula Sales (Tons) by Sales Channel (2027–2032)
 Table 62. Global HMO Infant Formula Sales Market Share by Sales Channel (2021–2026)
 Table 63. Global HMO Infant Formula Sales Market Share by Sales Channel (2027–2032)
 Table 64. Global HMO Infant Formula Revenue (US$ Million) by Sales Channel (2021–2026)
 Table 65. Global HMO Infant Formula Revenue (US$ Million) by Sales Channel (2027–2032)
 Table 66. Global HMO Infant Formula Revenue Market Share by Sales Channel (2021–2026)
 Table 67. Global HMO Infant Formula Revenue Market Share by Sales Channel (2027–2032)
 Table 68. Global HMO Infant Formula Price (US$/kg) by Sales Channel (2021–2026)
 Table 69. Global HMO Infant Formula Price (US$/kg) by Sales Channel (2027–2032)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. Abbott HMO Infant Formula Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Mead Johnson（Reckitt） Company Information
 Table 76. Mead Johnson（Reckitt） Description and Business Overview
 Table 77. Mead Johnson（Reckitt） HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. Mead Johnson（Reckitt） HMO Infant Formula Product
 Table 79. Mead Johnson（Reckitt） Recent Developments/Updates
 Table 80. Nestlé（Wyeth Nutrition） Company Information
 Table 81. Nestlé（Wyeth Nutrition） Description and Business Overview
 Table 82. Nestlé（Wyeth Nutrition） HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Nestlé（Wyeth Nutrition） HMO Infant Formula Product
 Table 84. Nestlé（Wyeth Nutrition） Recent Developments/Updates
 Table 85. Danone (Aptamil) Company Information
 Table 86. Danone (Aptamil) Description and Business Overview
 Table 87. Danone (Aptamil) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. Danone (Aptamil) HMO Infant Formula Product
 Table 89. Danone (Aptamil) Recent Developments/Updates
 Table 90. FrieslandCampina (Friso) Company Information
 Table 91. FrieslandCampina (Friso) Description and Business Overview
 Table 92. FrieslandCampina (Friso) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. FrieslandCampina (Friso) HMO Infant Formula Product
 Table 94. FrieslandCampina (Friso) Recent Developments/Updates
 Table 95. Biostime Company Information
 Table 96. Biostime Description and Business Overview
 Table 97. Biostime HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 98. Biostime HMO Infant Formula Product
 Table 99. Biostime Recent Developments/Updates
 Table 100. Yili Group (Ausnutria Dairy) Company Information
 Table 101. Yili Group (Ausnutria Dairy) Description and Business Overview
 Table 102. Yili Group (Ausnutria Dairy) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 103. Yili Group (Ausnutria Dairy) HMO Infant Formula Product
 Table 104. Yili Group (Ausnutria Dairy) Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. HMO Infant Formula Distributors List
 Table 108. HMO Infant Formula Customers List
 Table 109. HMO Infant Formula Market Trends
 Table 110. HMO Infant Formula Market Drivers
 Table 111. HMO Infant Formula Market Challenges
 Table 112. HMO Infant Formula Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HMO Infant Formula
 Figure 2. Global HMO Infant Formula Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global HMO Infant Formula Market Share by Type: 2025 & 2032
 Figure 4. 2'-Fucosyllactose (2'-FL) Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global HMO Infant Formula Market Value by Sales Channel (US$ Million), 2021–2032
 Figure 7. Global HMO Infant Formula Market Share by Sales Channel: 2025 & 2032
 Figure 8. Online Channel
 Figure 9. Specialty Store
 Figure 10. Supermarket
 Figure 11. Others
 Figure 12. Global HMO Infant Formula Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global HMO Infant Formula Market Size (US$ Million), 2021–2032
 Figure 14. Global HMO Infant Formula Sales (Tons), 2021–2032
 Figure 15. Global HMO Infant Formula Average Price (US$/kg), 2021–2032
 Figure 16. HMO Infant Formula Report Years Considered
 Figure 17. HMO Infant Formula Sales Share by Manufacturers in 2025
 Figure 18. Global HMO Infant Formula Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global HMO Infant Formula Players: Market Share by Revenue in HMO Infant Formula in 2025
 Figure 20. HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global HMO Infant Formula Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America HMO Infant Formula Sales Market Share by Country (2021–2032)
 Figure 23. North America HMO Infant Formula Revenue Market Share by Country (2021–2032)
 Figure 24. United States HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe HMO Infant Formula Sales Market Share by Country (2021–2032)
 Figure 27. Europe HMO Infant Formula Revenue Market Share by Country (2021–2032)
 Figure 28. Germany HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific HMO Infant Formula Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific HMO Infant Formula Revenue Market Share by Region (2021–2032)
 Figure 35. China HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America HMO Infant Formula Sales Market Share by Country (2021–2032)
 Figure 43. Latin America HMO Infant Formula Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa HMO Infant Formula Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa HMO Infant Formula Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE HMO Infant Formula Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of HMO Infant Formula by Type (2021–2032)
 Figure 54. Global Revenue Market Share of HMO Infant Formula by Type (2021–2032)
 Figure 55. Global HMO Infant Formula Price (US$/kg) by Type (2021–2032)
 Figure 56. Global Sales Market Share of HMO Infant Formula by Sales Channel (2021–2032)
 Figure 57. Global Revenue Market Share of HMO Infant Formula by Sales Channel (2021–2032)
 Figure 58. Global HMO Infant Formula Price (US$/kg) by Sales Channel (2021–2032)
 Figure 59. HMO Infant Formula Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Organic Infant Formula Milk Powder Market
Global Cow Milk Infant Formula Market Insights Forecast to 2030
Global Human Milk Oligosaccharides in Infant Formula Market Research Report 2024
Global Human Milk Oligosaccharides HMO Market Insights Forecast to 2030
Global Human Milk Oligosaccharides Market Research Report 2024
Global Biosynthetic Human Milk Oligosaccharides HMOs Market Research Report 2025
Global Sialylated Human Milk Oligosaccharides HMO Market Research Report 2024
Global HMO Children s Formula Milk Powder Market Research Report 2024
Global HMO Formula Milk Market Research Report 2024
Global HMO Children s Milk Powder Market Research Report 2024
Oligosaccharide for Infant Formula Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HMO Toddler Formula Milk Powder Market Research Report 2024
Global Cow s Milk Organic Infant Formula Market Research Report 2024
Global DHA Powder for Infant Formula Market Insights Forecast to 2030
Global OPO containing Infant Formulas Market Research Report 2024
Global HMO Milk Powder Market Research Report 2024
Global Gentle Organic Infant Formula Market Research Report 2025
Infant Milk Powder Market
Global Infant Formula Milk Powder Market Insights Forecast to 2030
Global Goat Milk Infant Formula Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions